Health Condition 1: E669- Obesity, unspecified
Conditions
Interventions
Intervention1: Shred â??Nâ?? Fit: 1 capsule & 1 protein sachet in the morning for 30 days
1 capsule & 1 protein sachet in the evening for 30 days
Control Intervention1: Placebo: 1 capsule & 1 protein
Sponsors
Gangwal Healthcare Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and/or female volunteers aged between >=18 to 65>= years. 2. Subjects with BMI >= 25Kg/m2 and 34.9>= kg/m2. 3. Subjects who are willing to do exercise for a span of 30 minutes daily for at least 5 days in a week. 4. Subjects who are willing to follow diet advised by investigator. 5. Subjects who are willing to give Inform consent. 6. Subjects who are willing to come for regular follow-up visits.
Exclusion criteria
Exclusion criteria: 1. Subjects having intake of over-the-counter weight loss agents, centrally acting appetite suppressants or prior surgery for obesity in the previous three months or planning to undergo such surgery within 2 months. 2. History of pathophysiologic/genetic syndromes associated with obesity (Cushingâ??s syndrome, Turnerâ??s syndrome, and Parder- Willi Syndrome). 3. Alcoholics and subjects with substance abuse. 4. Subject with evidence of malignancy. 5. Subjects having history of underlying inflammatory arthropathy, septic arthritis, inflammatory joint disease, gout, pseudo gout, Pagetâ??s disease, joint fracture, acromegaly, fibromyalgia, rheumatoid arthritis. 6. Subjects having history of coagulopathies, cardiovascular diseases, asthma. 7. Pregnant and lactating women. 8. Subjects with hepatic and renal failure. 9. Subjects on prolonged ( > 6 weeks) medication with corticosteroids, antidepressants, anticholinergics, etc. or any other drugs that may have an influence on the outcome of the study. 10. Subjects with hypersensitivity to any one ingredient of the drugs. 11. Subjects who have participated in other trial within last 3 months. 12. Any other condition which the principal investigator thinks may jeopardize the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in body weightTimepoint: Baseline to week 4. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in anthropometric measurements 2. Change in lipid profile 3. Change in quality of life 4.Global assessment for overall improvement by investigator and by patientTimepoint: Baseline to week 4. | — |
Countries
India
Contacts
Public ContactNeha Gondhale
Alchemy Clinical Research Services
Outcome results
None listed